Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma
Nature Clinical Practice Oncology · 2008-11 · 5 (11) · 630-631
DOI: 10.1038/ncponc1216 ↗Kurz gefasst
Kommentar in der Zeitschrift Nature Clinical Practice Oncology, online erschienen am 19.08.2008. Verfasst von Myron Schwartz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Radiology, The Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, NY 10029, USA. myron.schwartz@mo…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Surgery and Radiology, The Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, NY 10029, USA. myron.schwartz@mountsinai.org
Zitieren
APA
Schwartz, M., & Weintraub, J. (2008). Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nature Clinical Practice Oncology, 5(11), 630-631. https://doi.org/10.1038/ncponc1216
Vancouver
Schwartz M, Weintraub J. Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nature Clinical Practice Oncology. 2008;5(11):630-631. doi:10.1038/ncponc1216
BibTeX
@article{Schwartz2008,
author = {Schwartz, Myron and Weintraub, Joshua},
title = {Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma},
journal = {Nature Clinical Practice Oncology},
year = {2008},
volume = {5},
number = {11},
pages = {630--631},
doi = {10.1038/ncponc1216}
}
EUVIMED